Back

C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Takeshi Soeki

Tokushima University, Tokushima (Japan)

21 More presentations in this session

Presentation thumbnail
Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
Associate Professor H. Fukuta (Nagoya, JP)
Abstract
Presentation thumbnail
Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
Doctor K. Kopeva (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction
Doctor Q. Wang (Lanzhou, CN)
Abstract
Presentation thumbnail
Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.
Doctor M. Kurkina (Moscow, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources